Ch
Children's Oncology Grp
NPMonrovia CAFounded 2000
Private CapacadPrivateOncology
Platform: Coop Group
Market Cap
N/A
All Drugs
5
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CHI-IIT-120 | CHI-IIT-120 | Phase 2/3 | 1 | BCL-2 | GIST | ||
| CHI-IIT-162 | CHI-IIT-162 | Preclinical | 1 | DLL3 | CML | ||
| CHI-IIT-214 | CHI-IIT-214 | Phase 3 | 1 | LAG-3 | Atopic Derm | ||
| CHI-IIT-962 | CHI-IIT-962 | Preclinical | 1 | KIF18A | Bladder Ca | ||
| CHI-IIT-401 | CHI-IIT-401 | Phase 2/3 | 1 | IL-17A | T2D |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)